Physician profile
Deena Krishna
NPI 1891139911
$5,818.26
in general payments reported to CMS, 2019-2025
34 companies · $206 in 2025
The $206 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $821 · 2022: $1,875 · 2023: $2,159 · 2024: $757 · 2025: $206.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,122.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,122.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,078.08 | 2021-2023 | Fasenra, Tezspire, Breztri |
| Glaxosmithkline, LLC. | $656.69 | 2021-2023 | Nucala, Trelegy Ellipta |
| Janssen Pharmaceuticals, INC | $639.19 | 2021-2024 | Xarelto |
| Takeda Pharmaceuticals U.S.A., INC. | $597.24 | 2021-2023 | Glassia |
| Philips North America LLC | $435.71 | 2021-2024 | (Cm9) Amb Mon & Diag Und |
| Boehringer Ingelheim Pharmaceuticals, INC. | $364.43 | 2022-2023 | Ofev, Stiolto Respimat, Spiriva Respimat |
| Insmed, INC. | $207.87 | 2022-2023 | Arikayce |
| Mylan Specialty L.P. | $200.20 | 2021-2023 | Yupelri |
| Regeneron Healthcare Solutions, INC. | $181.16 | 2022-2023 | Dupixent |
| Kerecis Limited | $137.35 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Bayer Healthcare Pharmaceuticals INC. | $123.16 | 2022-2023 | |
| Axsome Therapeutics, INC. | $121.90 | 2022-2023 | Sunosi |
| Grifols USA, LLC | $112.24 | 2022-2023 | Prolastin-C Liquid |
| Covis Pharma Gmbh | $100.20 | 2022-2023 | |
| Paratek Pharmaceuticals, INC. | $91.69 | 2024-2025 | Nuzyra |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $89.20 | 2022-2023 | |
| United Therapeutics Corporation | $71.05 | 2022-2023 | Tyvaso |
| Boston Scientific Corporation | $68.41 | 2025 | Watchman Flx, Enroute Transcarotid Neuroprotection System |
| Amgen INC. | $61.85 | 2023 | Tezspire |
| Genentech, INC. | $59.65 | 2021 | |
| Abiomed | $40.21 | 2024 | Impella |
| Bolton Medical INC | $38.60 | 2025 | Relay Thoracic Stent-Graft With Plus Delivery System |
| Vapotherm INC | $38.41 | 2022 | |
| Resmed Corp | $36.77 | 2023-2025 | |
| Stryker Corporation | $35.84 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Merck Sharp & Dohme LLC | $35.25 | 2023 | Verquvo, Zerbaxa, Belsomra |
| Jazz Pharmaceuticals INC. | $31.18 | 2022 | |
| Ethicon US, LLC | $25.83 | 2024 | Vistaseal, Evarrest, Surgicel Nu-Knit |
| Solventum Corporation | $24.75 | 2025 | Activ.A.C. |
| Baxter Healthcare | $24.09 | 2023 | Hillrom - Life 2000 Ventilation System |
| Teva Pharmaceuticals USA, INC. | $23.64 | 2021 | |
| Kiniksa Pharmaceuticals International, Plc | $22.94 | 2024 | Arcalyst |
| Nevro Corp. | $22.42 | 2024 | Senza |
| Novo Nordisk INC | $21.06 | 2024 | Rybelsus, Ozempic |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deena Krishna listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.